These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10502720)

  • 1. Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival.
    Edwards SM; Badzioch MD; Minter R; Hamoudi R; Collins N; Ardern-Jones A; Dowe A; Osborne S; Kelly J; Shearer R; Easton DF; Saunders GF; Dearnaley DP; Eeles RA
    Int J Cancer; 1999 Oct; 84(5):458-65. PubMed ID: 10502720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor polymorphisms and the incidence of prostate cancer.
    Chen C; Lamharzi N; Weiss NS; Etzioni R; Dightman DA; Barnett M; DiTommaso D; Goodman G
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1033-40. PubMed ID: 12376504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive association of the androgen receptor CAG repeat length polymorphism with the risk of prostate cancer.
    Paz-Y-Miño C; Robles P; Salazar C; Leone PE; García-Cárdenas JM; Naranjo M; López-Cortés A
    Mol Med Rep; 2016 Aug; 14(2):1791-8. PubMed ID: 27357524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
    Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
    Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
    Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
    Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal cancer risk in relation to GGC and CAG trinucleotide repeat lengths in the androgen receptor gene.
    Dietzsch E; Laubscher R; Parker MI
    Int J Cancer; 2003 Oct; 107(1):38-45. PubMed ID: 12925954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor gene polymorphism and prostate cancer in Taiwan.
    Huang SP; Chou YH; Chang WS; Wu MT; Yu CC; Wu T; Lee YH; Huang JK; Wu WJ; Huang CH
    J Formos Med Assoc; 2003 Oct; 102(10):680-6. PubMed ID: 14691592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.
    Suter NM; Malone KE; Daling JR; Doody DR; Ostrander EA
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):127-35. PubMed ID: 12582022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor CAG polymorphism and prostate cancer risk.
    Mononen N; Ikonen T; Autio V; Rökman A; Matikainen MP; Tammela TL; Kallioniemi OP; Koivisto PA; Schleutker J
    Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer.
    Irvine RA; Yu MC; Ross RK; Coetzee GA
    Cancer Res; 1995 May; 55(9):1937-40. PubMed ID: 7728763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor GGC polymorphism and testosterone levels associated with high risk of prostate cancer and benign prostatic hyperplasia.
    Biolchi V; Silva Neto B; Pianta DB; Koff WJ; Berger M; Brum IS
    Mol Biol Rep; 2013 Mar; 40(3):2749-56. PubMed ID: 23184046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression.
    Nam RK; Elhaji Y; Krahn MD; Hakimi J; Ho M; Chu W; Sweet J; Trachtenberg J; Jewett MA; Narod SA
    J Urol; 2000 Aug; 164(2):567-72. PubMed ID: 10893645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk.
    Salinas CA; Austin MA; Ostrander EO; Stanford JL
    Prostate; 2005 Sep; 65(1):58-65. PubMed ID: 15810021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer.
    Hakimi JM; Schoenberg MP; Rondinelli RH; Piantadosi S; Barrack ER
    Clin Cancer Res; 1997 Sep; 3(9):1599-608. PubMed ID: 9815849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of tri-nucleotide (CAG and GGC) repeat polymorphism of androgen receptor gene in Taiwanese women with refractory or remission rheumatoid arthritis.
    Yu SF; Cheng TT; Hsu YH; Lai HM; Chen YC; Chiu CK; Lin KM; Chang C; Chen CJ; Kang HY
    Clin Rheumatol; 2007 Dec; 26(12):2051. PubMed ID: 17431729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients.
    Strom SS; Gu Y; Zhang H; Troncoso P; Babaian RJ; Pettaway CA; Shete S; Spitz MR; Logothetis CJ
    Prostate; 2004 Sep; 60(4):343-51. PubMed ID: 15264247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effects of androgen receptor gene trinucleotide repeats and prostate-specific antigen gene polymorphisms on prostate cancer.
    Alptekin D; Izmirli M; Bayazit Y; Luleyap HU; Yilmaz MB; Soyupak B; Erkoc MA; Tansug Z
    Genet Mol Res; 2012 May; 11(2):1424-32. PubMed ID: 22653589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers.
    Kadouri L; Easton DF; Edwards S; Hubert A; Kote-Jarai Z; Glaser B; Durocher F; Abeliovich D; Peretz T; Eeles RA
    Br J Cancer; 2001 Jul; 85(1):36-40. PubMed ID: 11437399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk.
    Chang BL; Zheng SL; Hawkins GA; Isaacs SD; Wiley KE; Turner A; Carpten JD; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB; Xu J
    Hum Genet; 2002 Feb; 110(2):122-9. PubMed ID: 11935317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk.
    Bratt O; Borg A; Kristoffersson U; Lundgren R; Zhang QX; Olsson H
    Br J Cancer; 1999 Oct; 81(4):672-6. PubMed ID: 10574254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.